Hanmi Pharm reports strong 1st-quarter results

Published: 2004-05-19 06:36:00

Updated: 2004-05-19 06:36:00

Hanmi Pharm, which made new launchings of nefedipine (a generic version of Bayer's Adalat Oros with 25 billion won in sales) and Testogel (testosterone) for men in April, reported a strong performance for its fiscal first quarter and this bullish trend will continue, according to a local bourse s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK